Skip to main content
Premium Trial:

Request an Annual Quote

GenoLogics, Rosetta Biosoftware, BlueGnome

Premium
GenoLogics this week launched Geneus 4.0, the latest version of its lab and data management system for genomics research.
 
According to GenoLogics, Geneus 4.0 can now handle data from next-generation sequencing platforms, such as Illumina’s Genome Analyzer. The updated system also provides advanced querying and reporting capabilities along with a secure web interface to facilitate collaboration.
 

 
Rosetta Biosoftware this week launched its Syllego System Version 2.0, a software package for genetic data management and analysis.
 
Syllego allows users to integrate microarray, next-generation sequencer, and clinical data in genetic studies. According to Rosetta, the new version of Syllego has been enhanced with an expanded set of data analysis tools, a new user interface, and the ability to use server-side processing.
 

 
BlueGnome last week launched BlueFISH, a library of 26,000 pre-labeled probes for fluorescent in situ hybridization.
 
The BlueFISH library is derived from the Roswell Park Cancer Institute’s library of bacterial artificial chromosomes and allows tiling of the complete human genome.
 
BlueGnome said that the library can be used to confirm results from its CytoChip microarray platform and other microarray platforms.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.